Assyro AI

Orange Book product · Brand (NDA)

NUEDEXTA

DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE

Brand (NDA)NDA 021879TE ABRX OTSUKA AMERICA PHARM

At a glance

Oct 29, 2010

Approved

Brand (NDA)

Application

AB

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 29, 2010

    15 yr 10 mo ago

  2. Today

  3. Patent 7659282 expires

    Listed method-of-use patent (U-1093) expiration.

    Aug 13, 2026

    in 2 mo

Pharmaceutical detail

Active ingredient

DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE

Strength

20MG;10MG

Dosage form

CAPSULE

Route

ORAL

TE code

AB

Application

NDA 021879

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7659282Aug 13, 2026in 2 mo
U-1093
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.